Rhythm Pharmaceuticals buy BiotechBee
Start price
03.09.23
/
50%
€25.20
Target price
31.12.25
€35.00
Performance (%)
-6.35%
End price
05.09.23
€23.60
Summary
This prediction ended on 05.09.23 with a price of €23.60. With a performance of -6.35%, the BUY prediction for Rhythm Pharmaceuticals by BiotechBee closed slightly in the red. BiotechBee has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rhythm Pharmaceuticals | 0.000% | 0.000% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
According to BiotechBee what are the pros and cons of Rhythm Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Buy mit Kursziel 35,0
In the thread Trading Rhythm Pharmaceuticals
Buy beendet
Current prediction by BiotechBee for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€25.60
12.11.23
12.11.23
€35.00
30.09.25
30.09.25
42.97%
07.05.24
07.05.24
Could be very worthwhile Investment >20% year